Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Eli Lilly
Eli Lilly
Eli Lilly’s Second Quarter Earnings Sneak Peek
Wall St. Cheat Sheet
Mon, 07/23/12 - 10:19 am
Eli Lilly
earnings
A Busy Week For Bio-Pharma Earnings, Drug Approvals
TheStreet.com
Mon, 07/23/12 - 09:15 am
drug approvals
earnings
Amylin
InterMune
Human Genome Sciences
GSK
Bristol-Myers Squibb
Questcor
BiogenIdec
Alexion
Regeneron
Eli Lilly
Amarin
Horizon Pharma
Celgene
Amgen
Gilead
Alkermes
United Therapeutics
Roche
Sanofi
Merck
AstraZeneca
Salix
Progenics Pharmaceuticals
Personalized Medicine Plus Diagnostics Equals Profits for Investors
Motley Fool
Sat, 07/21/12 - 11:58 am
Therascreen
Qiagen
Eli Lilly
Bristol-Myers Squibb
Agilent
The Market Has Already Discounted Merck's New Drug
Seeking Alpha
Fri, 07/20/12 - 09:30 am
Merck
Abbott Labs
Amgen
GSK
Pfizer
Eli Lilly
osteoporosis
Odanacatib
The Race For The Next Blockbuster Schizophrenia Drug
Seeking Alpha
Thu, 07/19/12 - 08:39 am
schizophrenia
Eli Lilly
Addex
BioLineRx
Lundbeck
Targacept
Pluristem Therapeutics' Answer To Big Pharma's Question: What Do We Do Now?
Seeking Alpha
Wed, 07/18/12 - 12:27 pm
Pluristem Therapeutics
Alkermes
AstraZeneca
Bristol-Myers Squibb
Isis Pharmaceuticals
Eli Lilly
Momenta
Merck
Pfizer
Sanofi
Spectrum Pharmaceuticals
Transition Therapeutics Awaiting Competing AD Trial Results
Seeking Alpha
Tue, 07/17/12 - 10:48 am
Transition Therapeutics
Elan
JNJ
Eli Lilly
Pfizer
Alzheimer's disease
Eli Lilly, Verastem and the Defenders of Shareholder Value
TheStreet.com
Mon, 07/16/12 - 12:16 pm
Eli Lilly
Verastem
Celgene
QLT
Amylin
Can Eli Lilly Save This Drug?
Motley Fool
Sun, 07/15/12 - 11:40 am
Eli Lilly
pomaglumetad methionil
schizophrenia
Alzheimer's Drug Research at Make or Break Juncture
Forbes
Fri, 07/13/12 - 12:45 pm
Alzheimer's disease
Merck
Pfizer
Eli Lilly
JNJ
Eli Lilly Stock Hits New 52-Week High
TheStreet.com
Fri, 07/13/12 - 12:21 pm
Eli Lilly
Lilly could net $1.5B-plus from Cymbalta extension
Fierce Pharma
Wed, 07/11/12 - 12:08 pm
Eli Lilly
Cymbalta
antidepressants
Closer Look: Furiex's Big Bounce
Seeking Alpha
Wed, 07/11/12 - 12:04 pm
Furiex Pharmaceuticals
JNJ
Takeda
Eli Lilly
Eli Lilly treatment for acute schizophrenia fails in late-stage study comparing it to placebo
Yahoo/AP
Wed, 07/11/12 - 11:42 am
Eli Lilly
schizophrenia
antipsychotics
pomaglumetad methionil
Eli Lilly's Cymbalta Gets Longer Market Exclusivity
investors.com
Sat, 07/7/12 - 11:49 am
Eli Lilly
Cymbalta
generics
Bristol-Myers Gets U.S. Approval For Wider Erbitux Use
Bloomberg
Fri, 07/6/12 - 07:21 pm
Bristol-Myers Squibb
colorectal cancer
Eli Lilly
Erbitux
Seven pharma companies partner with Gates Foundation to speed TB drug discovery
Yahoo/Fly on the Wall
Fri, 07/6/12 - 12:45 pm
tuberculosis
Bill Gates
Abbott Laboratories
AstraZeneca
Bayer
Eli Lilly
GSK
Merck
Sanofi
Lilly gains extension on pediatric Cymbalta exclusivity
Reuters
Fri, 07/6/12 - 11:04 am
Eli Lilly
Big Pharma’s Big Fines
ProPublica.org
Thu, 07/5/12 - 05:16 pm
fines
whistleblower lawsuits
Eli Lilly
Pfizer
AstraZeneca
Merck
Abbott Laboratories
GSK
Today's Bio Pharma Buyout News And Watch List
Seeking Alpha
Tue, 07/3/12 - 11:38 am
Amylin
AstraZeneca
Obagi Medical Products
Eli Lilly
GSK
Bristol-Myers Squibb
Pages
« first
‹ previous
…
109
110
111
112
113
114
115
116
117
…
next ›
last »